Pérez, Maeve Soto
Rodríguez-Capitán, Jorge
Requena-Ibáñez, Juan Antonio
Santos-Gallego, Carlos G.
Urooj Zafar, M.
Escolar, Ginés
Mancini, Donna
Mitter, Sumeet
Lam, David
Contreras, Johanna P.
Fergus, Icilma
Atallah-Lajam, Farah
Abascal, Vivian
Lala, Anu
Moreno, Pedro
Moss, Noah
Lerakis, Stamatios
Sanz, Javier
Fuster, Valentin
Badimon, Juan José http://orcid.org/0000-0002-6780-8771
Funding for this research was provided by:
“la Caixa” Foundation (LCF/BQ/EU21/11890141)
Lexicon Pharmaceuticals, Inc.
Article History
Accepted: 9 May 2023
First Online: 15 June 2023
Declarations
:
: All procedures performed in studies involving human participants are in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The protocol was approved by the Mount Sinai Institutional Review Board (GCO 22–0574) and received IND 165123 by the FDA.
: Informed consent is obtained from all individual participants included in the study.
: Not applicable.
: This study has been funded by an Investigator-Initiated Grant to Dr. Badimon by Lexicon Pharmaceuticals, Inc.